These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 7190279)

  • 61. Predictors of drug treatment response in obsessive-compulsive disorder.
    Ravizza L; Barzega G; Bellino S; Bogetto F; Maina G
    J Clin Psychiatry; 1995 Aug; 56(8):368-73. PubMed ID: 7635854
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Application of HPLC with silica-phase and reversed-phase eluents for the determination of clomipramine and demethylated and 8-hydroxylated metabolites.
    Coudoré F; Hourcade F; Molinier-Manoukian C; Eschalier A; Lavarenne J
    J Anal Toxicol; 1996; 20(2):101-5. PubMed ID: 8868400
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Single oral dose pharmacokinetics of clomipramine in depressed patients.
    Dawling S; Braithwaite RA; McAuley R; Montgomery SA
    Postgrad Med J; 1980; 56 Suppl 1():115-6. PubMed ID: 7393820
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Grapefruit juice as a contraindication? An approach in psychiatry].
    Vandel P; Regina W; Reix I; Vandel S; Sechter D; Bizouard P
    Encephale; 1999; 25(1):67-71. PubMed ID: 10205736
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clomipramine: plasma levels and clinical effects.
    Reisby N; Gram LF; Bech P; Sihm F; Krautwald O; Elley J; Ortmann J; Christiansen J
    Commun Psychopharmacol; 1979; 3(5):341-51. PubMed ID: 548213
    [No Abstract]   [Full Text] [Related]  

  • 66. Effects of physiological covariables on pharmacokinetic parameters of clomipramine in a large population of cats after a single oral administration.
    Lainesse C; Frank D; Beaudry F; Doucet M
    J Vet Pharmacol Ther; 2007 Apr; 30(2):116-26. PubMed ID: 17348896
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The pharmacokinetics of clomipramine and desmethylclomipramine in dogs: parameter estimates following a single oral dose and 28 consecutive daily oral doses of clomipramine.
    Hewson CJ; Conlon PD; Luescher UA; Ball RO
    J Vet Pharmacol Ther; 1998 Jun; 21(3):214-22. PubMed ID: 9673963
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
    Ballon N; Siobud-Dorocant E; Even C; Slama F; Dardennes R
    Encephale; 2001; 27(4):373-6. PubMed ID: 11686060
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The influence of lithium on fluvoxamine therapeutic efficacy and pharmacokinetics in depressed patients on combined fluvoxamine-lithium therapy.
    Miljković BR; Pokrajac M; Timotijević I; Varagić V
    Int Clin Psychopharmacol; 1997 Jul; 12(4):207-12. PubMed ID: 9347381
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Myoclonic movements as a side-effect of treatment with therapeutic doses of clomipramine.
    Casas M; Garcia-Ribera C; Alvarez E; Udina C; Queralto JM; Grau JM
    Int Clin Psychopharmacol; 1987 Oct; 2(4):333-6. PubMed ID: 3693873
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Plasma steady-state concentrations of hydroxylated metabolites of clomipramine.
    Linnoila M; Insel T; Kilts C; Potter WZ; Murphy DL
    Clin Pharmacol Ther; 1982 Aug; 32(2):208-11. PubMed ID: 7094507
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effect of clomipramine on prolactin levels--pilot studies.
    Francis AF; Williams P; Williams R; Link J; Cole EN; Hughes D
    Postgrad Med J; 1976; 52(3 suppl):87-92. PubMed ID: 959095
    [No Abstract]   [Full Text] [Related]  

  • 73. Paroxetine serum concentrations in depressed patients and response to treatment.
    Gilles M; Deuschle M; Kellner S; Shams M; Krumm B; Härtter S; Heuser I; Hiemke C
    Pharmacopsychiatry; 2005 May; 38(3):118-21. PubMed ID: 15902581
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A double-blind crossover trial of clomipramine for rapid ejaculation in 15 couples.
    Althof SE; Levine SB; Corty EW; Risen CB; Stern EB; Kurit DM
    J Clin Psychiatry; 1995 Sep; 56(9):402-7. PubMed ID: 7665538
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A fatality involving clomipramine.
    Fraser AD; Isner AF; Moss MA
    J Forensic Sci; 1986 Apr; 31(2):762-7. PubMed ID: 2872264
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical significance of plasma levels of clomipramine, its hydroxylated and desmethylated metabolites: prediction of clinical outcome in mood disorders using discriminant analysis of therapeutic drug monitoring data.
    Noguchi T; Shimoda K; Takahashi S
    J Affect Disord; 1993 Dec; 29(4):267-79. PubMed ID: 8126313
    [TBL] [Abstract][Full Text] [Related]  

  • 77. NET occupancy by clomipramine and its active metabolite, desmethylclomipramine, in non-human primates in vivo.
    Takano A; Nag S; Gulyás B; Halldin C; Farde L
    Psychopharmacology (Berl); 2011 Jul; 216(2):279-86. PubMed ID: 21336575
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Treatment of therapy resistant depressions with high dose clomipramine].
    Laux G; Reimer F
    Int Pharmacopsychiatry; 1979; 14(5):294-9. PubMed ID: 536186
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacokinetics of clomipramine in depressive patients.
    de Cuyper HJ; van Praag HM; Mulder-Hajonides WR; Westenberg HG; de Zeeuw RA
    Psychiatry Res; 1981 Apr; 4(2):147-56. PubMed ID: 6939006
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Assay of clomipramine and its demethylated derivative by liquid chromatography].
    Guyon F; Ni P; Jezequel M; Dupeyron JP
    Ann Biol Clin (Paris); 1987; 45(2):157-9. PubMed ID: 3619139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.